Periodic Reporting for period 1 - MOBILISE (Monoamine oxidase B inhibitors as novel drugs targeting NLRP3 inflammasome)

Although the number of anti-inflammatory drugs has increased during the past decade, there is still an urgent need to develop novel alternatives that overcome limitations of current treatments. The most used therapies, such as non-steroidal anti-inflammatory drugs, often...